Agilon Health (AGL) EBIAT (2020 - 2026)

Agilon Health (AGL) has 7 years of EBIAT data on file, last reported at $48.9 million in Q1 2026.

• For the quarter ending Q1 2026, EBIAT rose 2690.89% year-over-year to $48.9 million; the trailing twelve-month figure through Mar 2026 stood at -$354.5 million (down 39.16% YoY), and the FY2025 full-year result was -$391.3 million, down 50.46% from the prior year.
• EBIAT for Q1 2026 stood at $48.9 million, up from -$188.9 million in the prior quarter.
• Across five years, EBIAT topped out at $48.9 million in Q1 2026 and bottomed at -$234.8 million in Q4 2023.
• The 5-year median for EBIAT is -$30.4 million (2022), against an average of -$57.0 million.
• The widest annual swing landed in 2024, when EBIAT sank 428.3%; it then soared 2690.89% in 2026.
• A 5-year view of EBIAT shows it stood at -$56.0 million in 2022, then plunged by 319.62% to -$234.8 million in 2023, then jumped by 54.95% to -$105.8 million in 2024, then tumbled by 78.54% to -$188.9 million in 2025, then surged by 125.9% to $48.9 million in 2026.
• The last three EBIAT figures came in at $48.9 million (Q1 2026), -$188.9 million (Q4 2025), and -$110.2 million (Q3 2025), per Business Quant data.

Peer Comparison